Skip to main content
Genexine, Inc. logo

Genexine, Inc. — Investor Relations & Filings

Ticker · 095700 ISIN · KR7095700001 KO Manufacturing
Open in API
Filings indexed 341 across all filing types
Latest filing 2024-05-29 Regulatory Filings
Country KR South Korea
Listing KO 095700

About Genexine, Inc.

http://www.genexine.com/

Genexine, Inc. is a clinical-stage biotechnology company focused on developing and commercializing immunotherapeutics and next-generation biologics. The company utilizes its proprietary hyFc® platform technology to create long-acting protein therapeutics. Its pipeline is led by GX-I7, a long-acting interleukin-7 designed to amplify T-cell counts for immuno-oncology applications. Other key assets in late-stage clinical trials include GX-E4, a long-acting treatment for anemia, and GX-H9 for growth hormone deficiency. Genexine's research and development efforts primarily target oncology and rare diseases.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(임상시험계획승인신청등결정) (건강한 자원자 코카시안 및 아시아인에서 efepoetin alfa 단회 정맥 투여 후 약동/약력학적 특성, 안전성 및 내약성을 평가하기 위한 GX-E4 1상 임상계획 승인 )
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean Exchange (KRX) regarding a 'Major Management Matter' (투자판단 관련 주요경영사항), specifically the approval of a Phase 1 clinical trial for the drug GX-E4. Since this is a formal regulatory disclosure of a material event (clinical trial approval) that does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2024-05-29 Korean
[기재정정]소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a regulatory filing from Genexine regarding a legal proceeding (ICC international arbitration). It specifically details a 'lawsuit filing' (소송등의 제기) and provides updates on the claim amount. This falls under the category of legal proceedings and regulatory disclosures regarding litigation.
2024-05-20 Korean
분기보고서 (2024.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company Genexine (제넥신) covering the period from January 1, 2024, to March 31, 2024. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2024
2024-05-14 Korean
소송등의제기ㆍ신청(일정금액이상의청구)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure regarding a legal proceeding (ICC international arbitration) filed by Genexine. It details the plaintiff, the nature of the claim, the amount involved (67.9 billion KRW), and the company's planned response. This fits the definition of a Legal Proceedings Report (LTR) as it concerns a significant lawsuit/regulatory action.
2024-05-07 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official filing titled '정기주주총회결과' (Results of the Annual General Meeting) for the company Genexine. It details the outcomes of various agenda items voted upon during the meeting, including financial statement reporting, dividend decisions, director appointments, and remuneration limits. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2024-03-28 Korean
투자판단관련주요경영사항(임상시험계획승인신청) (건강한 자원자 코카시안 및 아시아인에서 efepoetin alfa 단회 정맥 투여 후 약동/약력학적 특성, 안전성 및 내약성을 평가하기 위한(GX-E4) 1상 임상계획 승인 신청)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Genexine regarding the submission of a Phase 1 clinical trial application (IND) to the Korean Ministry of Food and Drug Safety (MFDS). It details the clinical trial objectives, methodology, and potential risks to investors. Since it is a specific regulatory disclosure regarding clinical trial status and does not fit into categories like financial reports, dividends, or management changes, it is classified as a Regulatory Filing (RNS).
2024-03-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.